Recent studies have underscored the importance of tumor-resident type 1 conventional dendritic cells (cDC1) in orchestrating CD8+ T cell-mediated anti-cancer responses at the tumor-intrinsic stage [35]. The gene discussed is CD8A; the disease is cancer.